News Release<< Back
AtriCure Announces Launch of the cryoICE® cryoSPHERE™ Probe
cryoSPHERE probe launched in
The cryoSPHERE probe offers a unique 8mm ball-tip design, a bendable distal shaft, and an ergonomic handle to provide cardiac, thoracic, and general surgeons ease of use when applying the device to the targeted peripheral nerves to block pain. The launch of the cryoSPHERE probe demonstrates AtriCure’s commitment to continued innovation in Cryo Nerve Block Therapy (cryoNB).
“The addition of the cryoSPHERE probe to our pain management portfolio
is a major breakthrough in cardiac and thoracic surgery,” said
The cryoSPHERE technology uses a unique freezing method to temporarily block nerves from transmitting pain signals. The block typically lasts several months, during which time the nerve regenerates, giving the body time to heal. Because of the long-lasting nature of the therapy, physicians are adopting cryoNB as an adjunct to their pain management modalities, offering a unique solution for patients undergoing cardiothoracic surgery.
“Since incorporating the technique of a cryoNB in my thoracic surgical
practice several years ago, I have seen a remarkable improvement in
overall management of post-operative pain, post-operative recovery
times, and patient satisfaction,” said Dr.
Senior Director, Corporate Marketing and Communications
Senior Vice President and Chief Financial Officer